Key result
Short-term treatment with pioglitazone improved electrocardiogram parameters, including reducing QTc interval, and corrected heart rate variability in rats with isoproterenol-induced cardiac ischemia.
Why the study?
It was unknown whether short-term treatment with the PPAR-γ agonist pioglitazone could influence ECG parameters and HRV in isoproterenol-induced cardiac ischemia at rest and after phenylephrine injection.
Does pioglitazone improve electrocardiogram parameters and heart rate variability in a rat model of isoproterenol-induced cardiac ischemia?
Does pioglitazone improve electrocardiogram parameters and heart rate variability in a rat model of isoproterenol-induced cardiac ischemia?
In a rat model of cardiac ischemia, short-term pioglitazone treatment improved electrical conduction and heart rate variability, likely through modulation of inflammatory reactions.
Answers are grounded in this paper and cite their sources.
Pioglitazone improved ECG parameters and HRV in ischemic rats; hypothesis-generating for autonomic effects in cardiac ischemia, clinical translation unproven.
Background In this study, we aimed to determine whether short-term treatment with PPAR-γ agonist pioglitazone could influence electrocardiogram (ECG) parameters and heart rate variability (HRV) in isoproterenol-induced cardiac ischemia at rest and after phenylephrine injection. Methods Male Sprague-Dawley rats were divided into Sham, pioglitazone (PIO, 3 mg/kg, i.p.), isoproterenol-induced cardiac ischemia (ISO, 150 mg/kg, subcutaneously at 24-hour intervals on days 4 and 5), and PIO + ISO groups. Saline (in the Sham and ISO groups) or pioglitazone (in the PIO and PIO + ISO groups) were administered for 5 days. On day 6, tracheostomy and cannulation of the femoral artery and vein were performed under deep anesthesia. Then, blood pressure (BP) and ECG were recorded and HRV analysed. Results Baroreflex induced by intravenous injection of phenylephrine (10 µg/0.1 ml) increased BP and decreased heart rate (HR) in all groups. HR, QT interval, and QTc in the ISO group were more than in the Sham group at baseline and in baroreflex. Pioglitazone decreased the mentioned parameters in the PIO + ISO group. HRV analysis showed reductions in parasympathetic components of HRV in the ISO group, whereas pioglitazone corrected it in the PIO + ISO group. Cardiac markers, malondialdehyde, white blood cells, and heart/body weight ratio were more in the ISO group than those in the Sham group. All mentioned parameters were lower in the PIO + ISO group than those in the ISO group. Conclusion We indicated pioglitazone improves the electrical conduction of the heart and HRV in cardiac ischemia through modulating the inflammatory reactions.
No takes yet. Share an insight, caveat, or question.
Farokhipour et al. (2023) studied Isoproterenol-induced cardiac ischemia (n=64). Pioglitazone vs. Isoproterenol alone (ISO) or Saline (Sham) was evaluated on QTc interval at baseline (ms) (p=<0.05). Short-term treatment with pioglitazone improved electrocardiogram parameters, including reducing QTc interval, and corrected heart rate variability in rats with isoproterenol-induced cardiac ischemia.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: